Clicky

Initiator Pharma A/S(INIT)

Description: Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. It develops IP2018, a monoamine reuptake inhibitor for the treatment of psychogenic erectile dysfunction; IPED2015 to treat patients suffering from organic erectile dysfunction; and IPTN2021 for targeting an orphan drug indication in severe neuropathic pain. The company's pre-clinical stage candidates include IPNP2015 for the treatment of chronic pain; and IPDP2015 for depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.


Keywords: Pain Organ Systems Psychiatric Diagnosis Depression Chronic Pain Erectile Dysfunction Neuropathic Pain Peripheral Neuropathy Nociception Sexual Dysfunction

Home Page: www.initiatorpharma.com

Ole Maaloes vej 3
Copenhagen, 2200
Denmark
Phone: 45 61 26 00 35


Officers

Name Title
Dr. Claus Elsborg Olesen Co-Founder, CEO & Director
Dr. Dan Peters Co-Founder & CTO
Prof. Ulf Simonsen Ph.D. Co-Founder, CMO & CSO
Dr. Mikael Thomsen M.Sc., Ph.D. Co-Founder & CDO
Dr. Torgeir Vaage Chief Financial Officer
Dr. Allan Wehnert Sr. VP of Clinical and R&D Strategy & Portfolio Management
Susanne Thomsen Head of Clin Ops
Rene Egebro Head of CMC

Exchange: ST

Country: SE

Currency: Swedish krone (kr)

Forward PE: 9.8135
Trailing PE: 0
Price-to-Book MRQ: 5.6364
Price-to-Sales TTM: 0
IPO Date:
Fiscal Year End: December
Full Time Employees: 3
Back to stocks